JEREMY SKIECHS: Open Payments
NPI 1699242115 · NEW HARTFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,591 in 167 payments from 24 companies in 2025. Trend: 2023 $3,810 · 2024 $4,881 · 2025 $4,591
Food & beverage: $4,591
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $893 |
| AstraZeneca Pharmaceuticals LP | 19 | $886 |
| PFIZER INC. | 29 | $456 |
| Novo Nordisk Inc | 14 | $331 |
| Lilly USA, LLC | 15 | $321 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $249 |
| Amgen Inc. | 10 | $241 |
| Phathom Pharmaceuticals, Inc. | 3 | $171 |
| Abbott Laboratories | 3 | $170 |
| EMD Serono, Inc. | 1 | $125 |
Products named: QULIPTA, AIRSUPRA, VRAYLAR, BREZTRI, XIFAXAN, FARXIGA, VOQUEZNA, FREESTYLE LIBRE 3.
Industry payments across NY — which companies pay providers there.
